SkinHealth Systems (SKIN) risk factors, FY2025 10-K

SkinHealth Systems's FY2025 10-K, filed Mar 12, 2026, lists 88 risk factors in 12 groups. Against the prior year's 92: 3 new, 7 dropped, 16 substantially reworded.

Risk factors listed
8812 groups
New this year
3vs 92 last year
Dropped
7since the prior 10-K
Substantially reworded
16of those kept
Section length
33k wordsItem 1A

What the changes say

  • FDA turnover and political turmoil now threaten product reviews, approvals, enforcement consistency, and U.S. commercialization.
  • Manufacturing compliance shifts from QSR to QMSR on February 2, 2026, adding a specific regulatory transition.
  • The company added risks covering brand standards, changing commercialization rules, and reliance on stock-price appreciation rather than dividends.

What changed since the prior 10-K

New

  • NewRisks related to the beauty health industry

    Any damage to our reputation or brand may materially and adversely affect our business, financial condition and results of operations

    Brand damage from failures in ethical, social, product, labor, environmental, or consumer-experience standards could hurt growth.

  • NewRisks related to evolving laws and regulations and compliance with laws and regulations

    Uncertainty in regulatory frameworks and changes in applicable laws and regulations may affect our ability to commercialize products

    Changing product registration, safety, labeling, import/export, and commercial-practice rules could delay, restrict, or prevent sales.

  • NewRisks related to our securities

    We have never paid dividends on our capital stock and we do not intend to pay dividends for the foreseeable future. Consequently, any gains from an investment in our common stock will likely depend on whether the price of our common stock increases

    Because no dividends are planned, investors may realize gains only if Class A common stock appreciates.

Dropped

  • DroppedRisks related to the beauty health industry

    We believe that developing and maintaining our brand is critical and that our financial success is directly dependent on consumer perception of our brand. Furthermore, the importance of brand recognition may become even greater as our competitors offer more products that are similar to our products

  • DroppedRisks related to the beauty health industry

    ability to comply with ethical, social, product, labor and environmental standards. Any actual or perceived failure in compliance with such standards could damage our reputation and brand

  • DroppedRisks related to our business operations

    Our workforce reductions may cause undesirable consequences and our results of operations may be harmed

  • DroppedRisks related to information technology and cybersecurity

    Our e-commerce operations are important to our business. Our e-commerce websites serve as effective extensions of our marketing strategies by introducing potential new consumers to our brand, product offerings, providers and enhanced content

    Low consumer brand awareness compared with other beauty health brands.

  • DroppedRisks related to evolving laws and regulations and compliance with laws and regulations

    administrative or judicially imposed sanctions; the FDA’s refusal to grant pending or future clearances or approvals for products; clinical holds; refusal to permit the import or export of products; and/or criminal prosecution

    Brand damage from standards failures and inability to deliver innovative, competitively priced products.

  • DroppedRisks related to evolving laws and regulations and compliance with laws and regulations

    We have identified a material weakness in our internal control over financial reporting that could negatively impact our financial condition

  • DroppedRisks related to evolving laws and regulations and compliance with laws and regulations

    revenues. In addition, legal uncertainties about the legality of cookies and other tracking technologies may increase regulatory scrutiny and increase potential civil liability under data protection or consumer protection laws

Reworded

  • 95% rewrittenRisks related to evolving laws and regulations and compliance with laws and regulations

    New laws, regulations, enforcement trends, or changes in existing regulations could affect the ability of our esthetician providers in certain states to provide our treatments to consumers, any of which could have a material adverse effect on our business, financial condition, and results of operation

    The heading is broader, while the body removes the prior-year warning that regulatory compliance obligations are extensive and continuing.

  • 69% rewrittenRisks related to our business operations

    Our success depends, in part, on our retention of key members of our senior management team, whose continued service is not guaranteed, and ability to attract and retain qualified personnel

    The heading now expressly adds attracting qualified personnel; the supporting discussion is otherwise unchanged.

  • 63% rewrittenRisks related to conducting business internationally

    Disruption due to any government shutdown and personnel or policy changes at regulatory agencies, including the FDA, may hinder our ability to operate our business as intended

    The risk now specifically names FDA turnover, vacancies, shifting priorities, review delays, inconsistent enforcement, and delayed Delivery Systems and Consumable launches.

    Was: Personnel and policy changes at the regulatory agencies, including the FDA, may hinder our ability to operate our business as intended

  • 55% rewrittenRisks related to the beauty health industry

    Our new product introductions may not be, and at times in the past have not been, as successful as we anticipate

    The company says it has continued refining its process for developing, evaluating, and validating new products.

    Was: Our new product introductions may not be as successful as we anticipate

  • 45% rewrittenRisks related to conducting business internationally

    Our business could be negatively impacted by changes in the United States political environment

    The risk broadens from the 2025 administration and Congress to any U.S. legal, regulatory, or policy changes and adds shifting tariffs.

  • 43% rewrittenRisks related to our financial condition

    Our business could also be adversely affected by our inability to repay or refinance existing debt

    The debt is now identified as the 2026 Notes and linked to a September 14, 2021 indenture; the provided text is truncated.

  • 40% rewrittenRisks related to evolving laws and regulations and compliance with laws and regulations

    Our facilities are subject to regulation under the FDCA and FDA implementing regulations governing the manufacture of our products. If we fail to comply with federal, state and foreign regulations, our manufacturing operations could be halted, and our business would suffer

    Manufacturing compliance shifts from the QSR to the FDA’s QMSR on February 2, 2026, covering the same core controls and inspections.

  • 30% rewrittenRisks related to information technology and cybersecurity

    We are increasingly dependent on information technology, and if we are unable to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, our operations could be disrupted

    The provided current-year text is unchanged from the prior year, so there is no substantive risk change.

  • 29% rewrittenRisks related to evolving laws and regulations and compliance with laws and regulations

    As compliance with healthcare regulations becomes more costly and difficult for us or our customers, we may be unable to grow our business

  • 28% rewrittenRisks related to our securities

    We are currently, and may continue to be, subject to securities litigation, which is expensive to defend and could divert management’s attention

    Was: We may be subject to securities litigation, which is expensive to defend and could divert management’s attention

  • 26% rewrittenRisks related to evolving laws and regulations and compliance with laws and regulations

    Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations, and financial condition

  • 25% rewrittenRisks related to our financial condition

    If our cash from operations is insufficient to meet our current or future operating needs, expenditures and debt service obligations, our business, financial condition and results of operations may be materially and adversely affected

  • 25% rewrittenRisks related to information technology and cybersecurity

    We are subject to risks associated with product failure and/or technology flaws

  • 23% rewrittenRisks related to our business operations

    In order to deepen our market penetration and raise awareness of our brand and products, we continue to spend on marketing activities, which may not ultimately prove successful or an effective use of our resources

    Was: In order to deepen our market penetration and raise awareness of our brand and products, we have increased the amount we spend on marketing activities, which may not ultimately prove successful or an effective use of our resources

  • 22% rewrittenRisks related to our growth and profitability

    We have a history of operating losses and may experience future losses

  • 21% rewrittenRisks related to legal and regulatory proceedings

    We may incur substantial costs and receive adverse outcomes in litigation, regulatory investigations, and other legal matters in connection with alleged violations of securities laws and regulations

All 88 risk factors

Headings as the filing states them, in filing order.

Risks related to the beauty health industry

  1. 01The beauty health industry is highly competitive, and if we are unable to compete effectively, our results will suffer
  2. 02Our business is dependent on the commercial success and our ability to sell Delivery Systems. If we are unable to continue to successfully commercialize and sell our Delivery Systems, our results or operations and financial condition will be materially harmed
  3. 03Our new product introductions may not be, and at times in the past have not been, as successful as we anticipate55% rewritten
  4. 04Any damage to our reputation or brand may materially and adversely affect our business, financial condition and results of operationsNew
  5. 05Our success depends, in part, on the quality, efficacy and safety of our products
  6. 06The illegal distribution and sale by third parties of counterfeit versions of our products or the unauthorized diversion by third parties of our products could have an adverse effect on our net sales and a negative impact on our reputation and business
  7. 07Our reputation and brand may be negatively affected if our customers do not use our Delivery System as intended
  8. 08Demand for our products may not increase as rapidly as we anticipate due to a variety of factors including a weakness in general economic conditions and resistance to non-traditional treatment methods
  9. 09We may experience declines in average selling prices of our products which may decrease our net revenues

Risks related to our growth and profitability

  1. 10We may not be able to successfully implement our growth strategy
  2. 11Our growth and profitability are dependent on a number of factors, and any historical growth may not be indicative of future growth
  3. 12We may be unable to grow our business effectively or efficiently, which would harm our business, financial condition and results of operations
  4. 13Acquisitions or investments could disrupt our business and harm our financial condition
  5. 14If we are unable to address these difficulties and challenges or other problems encountered in connection with any acquisition or investment, we might not realize the anticipated benefits of that acquisition or investment and we might incur unanticipated liabilities or otherwise suffer harm to our business generally
  6. 15timing of industry tradeshows
  7. 16We have a history of operating losses and may experience future losses22% rewritten

Risks related to our business operations

  1. 17A disruption in our operations could materially and adversely affect our business
  2. 18Our success depends, in part, on our retention of key members of our senior management team, whose continued service is not guaranteed, and ability to attract and retain qualified personnel69% rewritten
  3. 19We also rely on providers and estheticians to promote our treatments, but they are not under any contractual obligations to do so or continue to do so
  4. 20We maintain single supply relationships for certain key components, and our business and operating results could be harmed if supply is restricted or ceases or the price of raw materials used in our manufacturing process increases
  5. 21We rely on third-party delivery service providers
  6. 22A disruption in the operations of our primary freight carrier or higher shipping costs could cause a decline in our net revenues or a reduction in our earnings
  7. 23If we fail to manage our inventory effectively, our results of operations, financial condition and liquidity may be materially and adversely affected
  8. 24In order to deepen our market penetration and raise awareness of our brand and products, we continue to spend on marketing activities, which may not ultimately prove successful or an effective use of our resources23% rewritten
  9. 25We manufacture and assemble our Delivery Systems in California, and if this site were to become compromised or damaged, our ability to continue to manufacture and assemble our products would be negatively affected
  10. 26We rely heavily on our sales professionals to market and sell our products worldwide. If we are unable to hire, effectively train, manage, improve the productivity of and retain our sales professionals, our business will be harmed, which would impair our future revenue and profitability
  11. 27Our providers generally are not under any obligation to purchase product, and business challenges at one or more of these providers could adversely affect our results of operations
  12. 28We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances or partnerships with third parties that may not result in the development of commercially viable products or product improvements or the generation of significant future revenues

Risks related to our financial condition

  1. 29Our business could also be adversely affected by our inability to repay or refinance existing debt43% rewritten
  2. 30If our cash from operations is insufficient to meet our current or future operating needs, expenditures and debt service obligations, our business, financial condition and results of operations may be materially and adversely affected25% rewritten
  3. 31The terms of our Notes require us to meet certain operating and financial covenants and place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our ability to operate our business
  4. 32We maintain our cash at financial institutions, often in balances that exceed federally insured limits
  5. 33Our ability to use any net operating loss carryforwards and certain other tax attributes may be limited
  6. 34Changes in tax law, our tax rates or our exposure to additional income tax liabilities or assessments could materially and adversely affect our business, financial condition and results of operations
  7. 35Our effective tax rate may vary significantly from period to period
  8. 36Fluctuations in currency exchange rates may negatively affect our financial condition and results of operations
  9. 37If our goodwill or long-lived assets become impaired, we may be required to record a significant charge to earnings
  10. 38Volatility in the financial markets could have a material adverse effect on our business
  11. 39Our sales and profitability may decline as a result of increasing costs and decreasing selling prices

Risks related to information technology and cybersecurity

  1. 40We are increasingly dependent on information technology, and if we are unable to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, our operations could be disrupted30% rewritten
  2. 41We must successfully maintain and upgrade our information technology systems, and our failure to do so could have a material adverse effect on our business, financial condition and results of operations
  3. 42Privacy and data protection laws increase our compliance burden
  4. 43We are subject to risks associated with product failure and/or technology flaws25% rewritten
  5. 44If we fail to adopt new technologies or adapt our e-commerce websites and systems to changing consumer demands or emerging industry standards, our business may be materially and adversely affected
  6. 45Failure to protect sensitive information of our consumers and information technology systems against security breaches could damage our reputation and brand and substantially harm our business, financial condition and results of operations
  7. 46Payment methods used on our e-commerce websites subject us to third-party payment processing-related risks
  8. 47We use AI in our business, and challenges with properly managing its use could result in harm to our brand, reputation, business or customers, and adversely affect our results of operations

Risks related to conducting business internationally

  1. 48International sales and operations comprise a significant portion of our business, which exposes us to foreign operational, political and other risks that may harm our business
  2. 49Adverse economic conditions in the United States, Europe, China or any of the other countries in which we may conduct business could negatively affect our business, financial condition and results of operations
  3. 50Legal, political, and economic uncertainty surrounding the exit of the United Kingdom from the European Union continue to be a source of instability and uncertainty
  4. 51We conduct business in China, which exposes us to risks inherent in doing business in that country
  5. 52Recent and potential additional tariffs imposed by the United States government on certain imports or a global trade war could increase the cost of our products, which could materially and adversely affect our business, financial condition and results of operations
  6. 53Our business could be negatively impacted by changes in the United States political environment45% rewritten
  7. 54Disruption due to any government shutdown and personnel or policy changes at regulatory agencies, including the FDA, may hinder our ability to operate our business as intended63% rewritten

Risks related to environmental, social, and governance issues

  1. 55Climate change and governmental actions to reduce such change may disrupt our operations and/or reduce consumer demand for our products
  2. 56Increased scrutiny from investors and others regarding our environmental, social, governance, or sustainability, responsibilities could result in additional costs or risks and adversely impact our reputation, employee retention, and willingness of customers and suppliers to do business with us

Risks related to evolving laws and regulations and compliance with laws and regulations

  1. 57New laws, regulations, enforcement trends or changes in existing regulations governing the introduction, marketing and sale of our products to consumers could harm our business
  2. 58New laws, regulations, enforcement trends, or changes in existing regulations could affect the ability of our esthetician providers in certain states to provide our treatments to consumers, any of which could have a material adverse effect on our business, financial condition, and results of operation95% rewritten
  3. 59Uncertainty in regulatory frameworks and changes in applicable laws and regulations may affect our ability to commercialize productsNew
  4. 60Our employees, consultants, and other commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements
  5. 61Our facilities are subject to regulation under the FDCA and FDA implementing regulations governing the manufacture of our products. If we fail to comply with federal, state and foreign regulations, our manufacturing operations could be halted, and our business would suffer40% rewritten
  6. 62Government regulations and private party actions relating to the marketing and advertising of our products and services may restrict, inhibit, or delay our ability to sell our products and harm our business, financial condition and results of operations
  7. 63Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud
  8. 64Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations, and financial condition26% rewritten
  9. 65Failure to comply with the U.S. FCPA, other applicable anti-corruption and anti-bribery laws, and applicable trade control laws could subject us to penalties and other adverse consequences
  10. 66As compliance with healthcare regulations becomes more costly and difficult for us or our customers, we may be unable to grow our business29% rewritten
  11. 67If we market products in a manner that violates healthcare laws, we may be subject to civil or criminal penalties
  12. 68Government regulation of the Internet and e-commerce is evolving, and unfavorable changes or failure by us to comply with these regulations could substantially harm our business, financial condition and results of operations

Risks related to legal and regulatory proceedings

  1. 69We are involved, and may become involved in the future, in disputes and other legal or regulatory proceedings that, if adversely decided or settled, could materially and adversely affect our business, financial condition and results of operations
  2. 70We sell products for human use. If we discover that any of our products are causing adverse reactions, we could suffer adverse publicity or regulatory or government sanctions
  3. 71Anti-takeover provisions of Delaware law and our Second Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws could delay and discourage takeover attempts that stockholders may consider to be favorable
  4. 72We may incur substantial costs and receive adverse outcomes in litigation, regulatory investigations, and other legal matters in connection with alleged violations of securities laws and regulations21% rewritten

Risks related to intellectual property

  1. 73We rely on trademark, copyright, trade secret, trade dress, patent and other laws protecting proprietary rights, nondisclosure and confidentiality agreements and other practices to protect our intellectual property, brand and proprietary information, technologies and processes
  2. 74If we are unable to protect the confidentiality of our trade secrets, our business or competitive position could be harmed
  3. 75Our success depends on our ability to operate our business without infringing, misappropriating or otherwise violating the trademarks, patents, copyrights and other proprietary rights of third parties
  4. 76We rely on licenses to use the intellectual property rights of third parties to conduct our business
  5. 77Third parties may assert ownership or commercial rights to inventions we develop or acquire
  6. 78We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties

Risks related to marketing activities

  1. 79Use of social media may materially and adversely affect our reputation or subject us to fines or other penalties
  2. 80Our business relies heavily on email and other messaging services, and any restrictions on the sending of emails or messages or an inability to timely deliver such communications could materially adversely affect our net revenue and business
  3. 81Our business could be negatively impacted by corporate citizenship and sustainability matters

Risks related to our securities

  1. 82Future offerings of debt or equity securities by us may adversely affect the market price of our Class A Common Stock and dilute our stockholders’ percentage ownership
  2. 83If securities or industry analysts cease to publish research, or publish inaccurate or unfavorable research, about our business, the price of our Class A Common Stock and trading volume could decline
  3. 84Our failure to meet Nasdaq’s continued listing requirements could result in a delisting of our Class A Common Stock
  4. 85Our outstanding warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results
  5. 86We are currently, and may continue to be, subject to securities litigation, which is expensive to defend and could divert management’s attention28% rewritten
  6. 87Actions of activist stockholders could be costly and time-consuming, divert management’s attention and resources, and have an adverse effect on our business
  7. 88We have never paid dividends on our capital stock and we do not intend to pay dividends for the foreseeable future. Consequently, any gains from an investment in our common stock will likely depend on whether the price of our common stock increasesNew

Other SkinHealth Systems 10-Ks

  • FY2024 10-K risk factors
    92 risks

    SkinHealth Systems depends heavily on manufacturing and selling its Vortex-Fusion Delivery Systems and related consumable products.

    Filed Mar 12, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.